British Land Company today fulfilled a regulatory requirement with a Rule 2.9 announcement, confirming its issued share capital and voting rights. This crucial update supports its ongoing recommended cash and share offer for Life Science REIT, providing essential share count details for investors tracking the acquisition.
British Land, a prominent property developer, has issued a Rule 2.9 announcement, updating its issued share capital and voting rights. This follows the company's previously announced recommended cash and share offer for Life Science REIT. The updated figures include the recent allotment of 2,708 ordinary shares to satisfy non-executive director fees.